EGF and cancer: Decreased EGF was found in 72% (18 out of 25) of the patients with a 97.8% specificity (1 out of 45 donors was detected as positive for cancer), when the mean value of the healthy group minus two standard deviations (425.6 pg ml−1) was used as the cutoff point.